However, we reveal that usage of an adipose tissue-selective mini-promoter within AAV vectors is an effective form of therapeutic intervention to restore metabolic health in severe forms of lipodystrophy such as CGL2. The gene discussed is GZMH; the disease is lipodystrophy.